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Blood based bioenergetic proﬁling strategies are emerging as potential reporters of systemic mi-
tochondrial function; however, the extent to which these measures reﬂect the bioenergetic capacity of
other tissues is not known. The premise of this work is that highly metabolically active tissues, such as
skeletal and cardiac muscle, are susceptible to differences in systemic bioenergetic capacity. Therefore,
we tested whether the respiratory capacity of blood cells, monocytes and platelets, are related to con-
temporaneous respirometric assessments of skeletal and cardiac muscle mitochondria. 18 female vervet/
African green monkeys (Chlorocebus aethiops sabaeus) of varying age and metabolic status were ex-
amined for this study. Monocyte and platelet maximal capacity correlated with maximal oxidative
phosphorylation capacity of permeabilized skeletal muscle (R¼0.75, 95% conﬁdence interval [CI]: 0.38–
0.97; R¼0.51, 95%CI: 0.05–0.81; respectively), isolated skeletal muscle mitochondrial respiratory control
ratio (RCR; R¼0.70, 95%CI: 0.35–0.89; R¼0.64, 95%CI: 0.23–0.98; respectively), and isolated cardiac
muscle mitochondrial RCR (R¼0.55, 95%CI: 0.22–0.86; R¼0.58, 95%CI: 0.22–0.85; respectively). These
results suggest that blood based bioenergetic proﬁling may be used to report on the bioenergetic ca-
pacity of muscle tissues. Blood cell respirometry represents an attractive alternative to tissue based
assessments of mitochondrial function in human studies based on ease of access and the minimal par-
ticipant burden required by these measures.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mitochondrial dysfunction is well recognized to play a key role
in a wide variety of diseases, particularly those associated with
aging. For this reason, assessments of mitochondrial function have
long been proposed to have signiﬁcant diagnostic and prognostic
applications. There is mounting evidence that blood cells canB.V. This is an open access article u
dy mass index; BSA, bovine
ex 2; EGTA, triethylene glycol
unosorbent assay; ETC,
riﬂuoromethoxy)phenylhy-
f insulin resistance; MAS,
ked bioenergetic capacity;
oros Oxygraph 2K; OXPHOS,
aline; PGE1, prostaglandin E1;
control ratio; SD, standard
olina).report on systemic mitochondrial function. Diabetes, athero-
sclerosis, and neurodegeneration are all related to the deteriora-
tion of various mitochondrial parameters in multiple cell types,
including leukocytes and platelets [1–4]. Changes in mitochondrial
DNA (mtDNA), mitochondrial enzyme activity, and electron
transport chain (ETC) activity measured in peripheral blood
mononuclear cells, monocytes, lymphocytes, and platelets have
been associated with mortality, diabetes, HIV, cardiovascular dis-
ease, Parkinson's disease, Alzheimer's disease, cancer, inﬂamma-
tion, cognition, Huntington's disease, sepsis, and ﬁbromyalgia
[1,5–18]. More recently, blood based bioenergetic proﬁling stra-
tegies utilizing cellular respirometry have been associated with
key features of aging such as gait speed, physical function decline,
inﬂammation, and depression [19–21].
Blood based measures of mitochondrial function may provide a
minimally invasive test that is particularly well suited for diag-
nostic use. In addition, these measures are highly amenable for use
in large scale clinical trials, including those with serial longitudinal
assessments, because they require minimal patient burden andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tion. Blood based bioenergetic proﬁling strategies are also well
suited for use in older adults who often present with multiple
contraindications to biopsy. However, little is known about whe-
ther these blood based measurements are able to recapitulate
measures of mitochondrial function performed in other tissues.
In this study, we examined the relationships of monocyte and
platelet mitochondrial respiration with assessments of mitochon-
drial function performed in muscle tissues. We focused on skeletal
and cardiac muscle because age-related bioenergetic decline is
thought to be most signiﬁcant in highly metabolically active tis-
sues and based on our previous ﬁndings that blood based re-
spirometry is positively correlated with measures of physical
function and strength in human subjects [20]. For example, ske-
letal muscle from older adults is reported to have reduced ATP
production, maximal bioenergetic capacity, and mitochondrial
content compared to younger counterparts [22]. In addition, car-
diac tissue oxidative capacity and phosphocreatine/ATP ratio are
reduced in the earliest stages of heart failure in humans [23],
which is further impaired by diabetes and obesity [24,25]. These
are similar to ﬁndings from rodent models [26,27]. The use of a
non-human primate model provided us with reliable access to
heart and skeletal muscle tissue and sufﬁcient volumes of blood to
permit the analyses of multiple blood cell populations. Vervet
macaques are susceptible to naturally occurring changes in body
composition [28], physical function [29], and chronic diseases
ranging from obesity [30], diabetes [31], and heart disease [32] as
they age in a manner similar to humans [33]. The present study
utilized a group of female vervet macaques speciﬁcally selected to
represent a wide range of metabolic health status and insulin re-
sistance as well as body mass indices from lean to obese across
young and old age groups. This design was utilized in order to
maximize the potential bioenergetic differences between animals.
Blood cell respiration was compared to skeletal muscle mi-
tochondrial function in two ways. Vastus lateralis muscle ﬁbers
were permeabilized and analyzed by high resolution respirometry
[34] to examine bioenergetic capacity in a manner that maintains
potential differences in mitochondrial content and architecture
[35]. In addition, we examined respiratory control in isolated
vastus lateralis mitochondria [36] to determine whether blood
based measures might be related to differences in intrinsic elec-
tron transport chain function. Similar methods using isolated or-
ganelles were carried out for analysis of cardiac muscle mi-
tochondrial function. We hypothesized that because blood cells
are continuously exposed to circulating factors such as in-
ﬂammatory cytokines, redox stress [37], and recently described
mitokines [38]; which are known to affect mitochondrial function
across tissues; respirometric analyses of monocytes and platelets
will recapitulate differences in systemic bioenergetic capacity.2. Materials and methods
2.1. Animal participants
This study included 18 female vervet/African green monkeys
(Chlorocebus aethiops sabaeus) ranging in age from 8.2 to 23.4 yrs.
The monkeys originally lived in stable social groups of 11–49 in
indoor-outdoor housing units with approximately 28 m2 indoors
and 111 m2 outdoors which contained perches, platforms, elevated
climbing structures and a base composed of smooth stones. Seven
of the 18 animals were moved to indoor housing (pair- or in-
dividually-housed) prior to study initiation. All animals were fed a
standard monkey chow diet (LabDiet 1538), supplemented with
fruits and vegetables 5 times per week. Water was available ad
libitum. Blood samples were obtained from anesthetized animalsimmediately prior to necropsy, and the harvest of skeletal and
cardiac muscle tissues. Euthanasia was carried out with IM keta-
mine (10–15 mg/kg) followed by IV sodium pentobarbital (60–
100 mg/kg) to attain deep surgical anesthesia and exsanguination
in accordance with guidelines established by the Panel on Eu-
thanasia of the American Veterinary Medical Association. All
procedures were approved and performed according to the
guidelines of state and federal laws, the US Department of Health
and Human Services, and the Animal Care and Use Committee of
Wake Forest School of Medicine.
2.2. Body mass measurements
BMI was estimated as the ratio of body mass to the square of
trunk length measured from the suprasternal notch to the pubic
symphysis using an electronic caliper (in kg/m2) and was calcu-
lated 4 months prior to necropsy while weight was measured at
the time of necropsy [39].
2.3. Insulin, glucose, and insulin sensitivity measurements
Fasting glucose was determined using reagents and in-
strumentation (ACE ALERA autoanalyzer) from Alfa Wasserman
Diagnostic Technologies (West Caldwell, NJ). Insulin was de-
termined by an enzyme-linked immunosorbent assay (ELISA;
Mercodia, Uppsala, Sweden). All analyses were performed in the
Wake Forest Comparative Medicine Clinical Chemistry and En-
docrinology Laboratory 4 months prior to necropsy. Homeostatic
model of insulin resistance (HOMA-IR)¼([mg/dL fasting glucose
X mIU/L fasting insulin]/405) was used as an estimate of insulin
resistance [40].
2.4. Isolation of blood cells
Blood (8 mL) was collected from fasted monkeys into acid ci-
trate dextrose (ACD) tubes (Vacutainer; Becton Dickinson, Franklin
Lakes, NJ) and processed immediately to obtain platelet and
CD14þ monocyte preparations. Platelets and CD14þ monocytes
were isolated using methods similar to those described by Chacko
et al. [41]. Brieﬂy, whole blood in ACD tubes was centrifuged at
500 g for 15 min at room temperature with the brake off. Platelet
rich plasma was removed and platelets were isolated by cen-
trifugation at 1500 g for 10 min, washed in phosphate-buffered
saline (PBS) with prostaglandin E1 (PGE1; Cayman Chemical, Ann
Arbor, MI), and resuspended in extracellular ﬂux (XF) assay buffer
(Seahorse Biosciences, North Billerica, MA) containing 1 mM Naþ-
pyruvate, 1 mM GlutaMAX (Gibco, Grand Island, NY), 11 mM D-
glucose, and PGE1 (pH 7.4) for respirometry experiments. The
buffy coat layer was extracted, diluted 4 in RPMI 1640 (Gibco)
and layered onto 3 mL of polysucrose solution at a density of
1.077 g/mL (Sigma Histopaques-1077, St. Louis, MO) in 15 mL
centrifuge tubes and centrifuged at 700 g for 30 min with no
brake. The buffy coat layer was obtained, washed in PBS, and di-
vided into 2 tubes. CD14þ monocytes were isolated from 1 tube
using CD14-labeled magnetic microbeads (Miltenyi Biotec, San
Diego, CA) according to manufacturer instructions using modiﬁed
RPMI 1640þfatty-acid free bovine serum albumin (BSA) media.
Monocytes were washed in modiﬁed RPMI 1640 media and re-
suspended in XF assay buffer without PGE1 for respirometry
experiments.
2.5. Respirometry of blood cells
A total of 250,000 monocytes and 25,000,000 platelets per well
were plated in quadruplicate in the Seahorse microplate. Bioe-
nergetic proﬁling using selected inhibitors and uncoupler have
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rate (OCR) measures were monitored while the cells respired in XF
assay buffer, followed by sequential additions of oligomycin
(750 nM), carbonyl cyanide-4-(triﬂuoromethoxy) phenylhy-
drazone (FCCP; 1 μM), and antimycin-Aþrotenone (A/R; both
1 μM) (all from Sigma) with measurements taken after each ad-
dition. MAX OCR was calculated after addition of FCCP, a potent
mitochondrial uncoupler. The use of FCCP as a chemical uncoupler
allows us to estimate maximal ETC activity and the supply of
substrates available for respiration. Reserve capacity was calcu-
lated as the difference between MAX and the basal OCR [43,44].
The difference between the measurement taken after the oligo-
mycin addition (oligo) and the A/R addition is reported as the leak
respiration and the difference between basal and oligo is the OCR
attributed to ATP [45]. Platelet respiration was normalized to mg
protein, determined by Pierce BCA assay (ThermoFisher Scientiﬁc,
Grand Island, NY).
2.6. Preparation of permeabilized skeletal muscle ﬁber bundles
Approximately 1 g of skeletal muscle tissue was obtained im-
mediately after euthanasia. A portion of each muscle sample was
immediately placed in ice-cold buffer X (50 mM K-MES, 7.23 mM
K2EGTA, 2.77 mM CaK2EGTA, 20 mM imidazole, 20 mM taurine,
5.7 mM ATP, 14.3 mM phosphocreatine and 6.56 mM MgCl2 6H2O,
pH 7.1) for preparation of permeabilized muscle ﬁber bundles
(PmFBs), as previously described [46]. About 2–4 mg ﬁber bundles
were separated along the longitudinal axis using needle-tipped
forceps under magniﬁcation, permeabilized with saponin
(30 μg mL1) for 30 min at 4 °C, and subsequently washed in ice-
cold buffer Z (105 mM K-MES, 30 mM KCl, 1 mM EGTA, 10 mM
K2HPO4, 5 mM MgCl2 6H2O, 0.5 mg mL1 BSA, pH 7.4) for
∼15 min prior to analysis. At the conclusion of each experiment,
PmFBs were washed in double-distilled H2O to remove salts, dried
under vacuum, and weighed. Typical ﬁber bundle sizes were 0.2–
0.6 mg dry weight.
2.7. Respirometry of permeabilized skeletal muscle ﬁber bundles
High-resolution O2 consumption measurements were con-
ducted in 2 mL of buffer Z containing 20 mM creatine and 25 μM
blebbistatin to inhibit contraction [46] using the OROBOROS
Oxygraph-2k (O2k; Oroboros Instruments, Innsbruck, Austria)
[34]. Polarographic O2 measurements were acquired at 2-s inter-
vals with the steady state rate of respiration calculated from a
minimum of 40 data points and expressed as pmol s1 per mg dry
weight. All respiration measurements were conducted at 37 °C and
a working range [O2] of 350–180 μM. Respiration was measured
in duplicate as follows: 2 mM malate (leak), 5 mM ADP, 5 mM
pyruvate, 10 mM glutamate (complex I OXPHOS substrates), fol-
lowed by sequential additions of 10 mM succinate (complex II
OXPHOS substrates), 1 μM cytochrome c to test for mitochondrial
membrane integrity, and sequential titrations of 1 mM FCCP
(MAX), and 2.5 μM antimycin-A þ0.5 μM rotenone (non-mi-
tochondrial respiration).
2.8. Isolation of mitochondria from skeletal and cardiac muscle
Mitochondria were isolated as previously described [36,47]
from both skeletal and cardiac muscle. For each animal, 50 mg of
tissue was minced into small pieces and resuspended in Chappell-
Perry Buffer I (CP I) containing 1 mg/mL Nagarse. After incuba-
tion with Nagarse for 5 min at room temperature, homogenization
was performed using a Bio Gen series Model PRO200 homogenizer
(Pro-Scientiﬁc, Inc., Oxford, CT) equipped with a 5 mm PRO quickconnect generator probe. The homogenized tissue was washed
with an equal volume of CP I and 2X volume of CP II buffer by
centrifuging at 600G at 4 °C for 10 min (Eppendorf centrifuge
5804R, Eppendorf AG, Hamburg, Germany). The resulting super-
natant was ﬁltered through cheese cloth and the ﬁltrate cen-
trifuged at 10,000 g at 4 °C for 10 min using a Beckman cen-
trifuge, model J2-21M Induction drive centrifuge (Beckman-Coul-
ter, Inc., Brea, CA) to obtain a mitochondrial pellet. The pellet was
further washed ﬁrst with CP II and then with CP I buffer. Finally,
the pellet was suspended in mitochondrial assay solution (man-
nitol and sucrose buffer: MAS; sucrose 35 mM, mannitol 110 mM,
KH2PO4 2.5 mM, MgCl2 2.5 mM, HEPES 1.0 mM, EGTA 0.5 mM,
fatty-acid free BSA 0.10%, pH 7.4) prior to respirometry. Puriﬁed
mitochondrial protein was determined according to manu-
facturer’s instructions by Pierce BCA assay (ThermoFisher Scien-
tiﬁc, Grand Island, NY). A typical yield of 500 μg of puriﬁed
mitochondria was obtained per 50 mg sample.
2.9. Respirometry of isolated mitochondria
Isolated mitochondria respirometry was performed using an
XF24–3 Extracellular Flux Analyzer (Seahorse Bioscience, North
Billerica, MA). The procedure was previously described by Rogers
et al. [48] and employed as previously described [36]. During study
protocol optimization, respiration driven by complex 1 using
pyruvate/malate was compared with respiration driven by com-
plex 2 using succinate/rotenone. Complex 2 driven respiration was
consistently higher, similar to previous reports [48]. In order to
ensure adequate sample size and standardization, isolated mi-
tochondrial respirometric analyses were performed using succi-
nate and rotenone. Compounds were prepared in 1X MAS at 10X
the ﬁnal concentration required for the assay. Final concentrations
of compounds were as follows: ADP, 2 μM oligomycin, 6 μM FCCP,
and 2 μM antimycin A. Five μg of the mitochondrial suspension
was added to each well and the plate centrifuged at 2000 g at
4 °C for 20 min to ensure attachment. After centrifugation, 450 mL
of 1X MAS containing succinate (10 mM) and rotenone (2 μM) was
gently added to each well and the experiment initiated. The re-
spirometric assay was performed at 37 °C. Primary outcomes
were: maximal State 3 respiration, initiated with ADP (MAX-A),
maximal FCCP-linked respiration (MAX), and State 4o, induced by
the inhibition of ATP synthase by the addition of oligomycin. The
respiratory control ratio (RCR) was calculated as MAX-A/State4o
(RCR-A) and MAX/State 4o (RCR-F).
2.10. Statistical analyses
Distributions of all variables were examined before any further
analysis. All variables satisﬁed the normality assumption as as-
sessed using Shapiro-Wilk tests. Associations between all variables
were assessed using Pearson correlation coefﬁcients (R) and fur-
ther separately controlled for age, weight, and HOMA-IR. Corre-
lations are tabulated for each blood cell type analyzed and re-
gression plots between some of the most commonly published
variables are depicted following each correlation table. The re-
gression plots we have chosen to show are between MAX re-
spiration of each blood cell type with complex I and complex Iþ II
OXPHOS from permeabilized skeletal muscle ﬁbers as well as
FCCP-linked MAX respiration and RCR-F from isolated mitochon-
dria from skeletal muscle and cardiac tissue. The analyses were
performed (SPSS v22; Armonk, NY). 95% conﬁdence intervals
(95%CI) were generated for the correlation coefﬁcients by
bootstrapping.
Table 1
Baseline characteristics of non-human primate subjects enrolled in this study.
Mean SD Range N
Age (years) 16.6 6.1 8.4–23.7 18
Weight (kg) 4.9 1.0 3.3–6.9 18
BMI (kg/m2) 60.7 10.5 44.6–82.3 18
Glucose (mg/dL) 127.7 70.6 73.0–319.0 18
Insulin (mIU/L) 23.7 26.7 4.6–114.6 18
HOMA-IR 6.9 7.1 1.0–27.2 18
BMI¼body mass index, HOMA-IR¼homeostatic model of insulin resistance,
SD¼standard deviation.
BMI was estimated using trunk length measured from the suprasternal notch to the
pubic symphysis.
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3.1. Demographic and bioenergetic parameters of non-human pri-
mate participants
Age, body weight, BMI, insulin, glucose, and homeostatic model
assessment of insulin resistance (HOMA-IR) are summarized in
Table 1. A total of 18 vervet macaques, all female, were studied
with a mean age of 16.4 years. The ages ranged from 8.4 to 23.7
years. The mean weight of the animals was 4.9 kg. Glucose and
insulin levels averaged 127.7 mg/dL and 23.7 mIU/L; respectively,
with median values of 98.0 mg/dL and 13.5 mIU/L; respectively,
indicating wide ranges of variability. The average HOMA-IR wasFig. 1. Representative bioenergetic proﬁles from CD14þ monocytes, platelets, skeleta
skeletal muscle ﬁbers from one animal. Respiration is measured as oxygen consumption
min/5 mg mitochondrial protein [left vastus and cardiac tissues]), and pmol/min/mg dry
(CII) respiration was measured using succinate and rotenone as substrates. Ama¼anti
ﬂuoromethoxyphenylhydrazone, G¼glutamate, M¼malate, O¼oligomycin, P¼pyruvate6.9 with a median of 4.0, indicating some animals to be insulin
resistant while others were insulin-sensitive [30]. Representative
bioenergetic proﬁles from each tissue of one animal are shown in
Fig. 1, and baseline bioenergetic parameters for each animal are
summarized in Table 2.
3.2. Correlations between monocyte blood cell bioenergetics with
isolated mitochondria from skeletal and cardiac muscle and per-
meabilized skeletal muscle ﬁbers
Pearson correlation coefﬁcients were used to compare all blood
cell bioenergetic parameters with skeletal and cardiac muscle
bioenergetics. The relationships between primary monocyte
bioenergetic parameters with skeletal and cardiac muscle bioe-
nergetics are summarized in Table 3 and regression plots depicting
these relationships can be found in Fig. 2. Maximal FCCP-linked
bioenergetic capacity (MAX) of CD14þ monocytes was sig-
niﬁcantly positively correlated with permeabilized skeletal muscle
maximal oxidative phosphorylation capacity (OXPHOS) driven
using substrates for complexes I and II (R¼0.75, CI: 0.38–0.97;
Fig. 2A) and substrates for complex I alone (R¼0.73, CI: 0.33–0.91;
Fig. 2B). In addition, basal respiration and reserve capacity of
monocytes were signiﬁcantly correlated with complex Iþ II and
complex I OXPHOS in permeabilized skeletal muscle ﬁbers.
Monocyte MAX also signiﬁcantly positively correlated with the
skeletal muscle isolated mitochondrial FCCP-linked respiratory
control ratio (RCR-F; R¼0.70, CI: 0.35–0.89; Fig. 2D) but notl muscle isolated mitochondria, cardiac isolated mitochondria, and permeabilized
rate (pmol/min/250,000 cells [monocytes], pmol/min/mg protein [platelets], pmol/
weight [permeabilized ﬁbers]. In isolated mitochondrial preparations, complex II
mycin-A, c¼cytochrome c, D¼adenosine diphosphate, F¼carbonyl-cyanide-p-tri-
, R¼rotenone, S¼succinate, U¼uncoupler (FCCP).
Table 2
Baseline bioenergetic characteristics of non-human primate subjects enrolled in
this study.
Mean SD Range N
Platelet basal 299.0 98.8 162.2–435.6 17
Platelet oligomycin OCR 98.3 26.4 54.4–140.4 15
Platelet MAX 438.1 159.8 209.3–699.5 17
Platelet non-mitochondrial OCR 84.4 23.3 36.1–124.4 17
Platelet reserve capacity 139.1 78.5 27.4–263.9 17
Platelet ATP OCR 198.4 77.9 76.8–304.0 15
Platelet leak OCR 12.2 13.5 7.2 to 39.1 15
Monocyte basal 79.6 37.3 39.3–158.8 11
Monocyte oligomycin OCR 25.2 9.4 13.7–37.3 9
Monocyte MAX 116.2 54.9 50.6–225.3 11
Monocyte non-mitochondrial OCR 19.0 12.7 8.8 to 37.9 11
Monocyte reserve capacity 36.6 19.6 10.7–66.4 11
Monocyte ATP OCR 48.8 24.8 19.6–86.5 9
Monocyte leak OCR 4.7 10.6 20.6 to 13.9 9
Permeabilized ﬁber basal 34.8 9.2 23.4–57.8 17
Permeabilized ﬁber leak OCR 33.6 12.2 21.0–67.1 17
Permeabilized ﬁber complex I OXPHOS 93.9 22.7 60.1–145.7 17
Permeabilized ﬁber complex Iþ II
OXPHOS
133.3 34.4 68.0–197.6 17
Permeabilized ﬁber cytochrome C mem-
brane integrity
132.7 35.8 63.5–200.3 17
Permeabilized ﬁber MAX 157.4 33.4 116.8–215.7 17
Permeabilized ﬁber non-mitochondrial
OCR
12.0 3.8 5.1–20.1 17
Left vastus isolated mitochondria CII oli-
gomycin OCR
117.4 50.8 43.0–240.5 16
Left vastus isolated mitochondria CII state
3
581.4 247.9 162.1–1082.1 16
Left vastus isolated mitochondria CII
MAX
601.2 292.1 156.6–1062.0 16
Left vastus isolated mitochondria CII RCR-
A
5.1 1.4 2.6–8.4 16
Left vastus isolated mitochondria CII RCR-
F
5.1 1.5 2.5–7.5 16
Cardiac isolated mitochondria CII oligo-
mycin OCR
162.6 68.2 47.2–268.5 16
Cardiac isolated mitochondria CII state 3 633.4 213.9 171.9–928.4 16
Cardiac isolated mitochondria CII MAX 669.1 225.7 265.6–1052.5 16
Cardiac isolated mitochondria CII RCR-A 4.1 1.0 2.8–6.8 16
Cardiac isolated mitochondria CII RCR-F 4.4 1.1 2.8–7.2 16
ATP¼adenosine triphosphate, CII¼complex 2, FCCP¼Carbonyl cyanide-4-(tri-
ﬂuoromethoxy) phenylhydrazone, MAX¼FCCP-linked respiration, OCR¼oxygen
consumption rate, OXPHOS¼oxidative phosphorylation capacity, RCR¼respiratory
control ratio.
Respiration is measured as oxygen consumption rate (pmol/min/mg protein [pla-
telets], pmol/min/250,000 cells [monocytes], pmol/min/mg dry weight [permea-
bilized ﬁbers], pmol/min/5 mg mitochondrial protein [left vastus and cardiac tis-
sues]).
In blood cell respiration, Reserve capacity is calculated as the difference between
MAX and Basal respiration and Leak is calculated as the difference between Oligo
and A/R respiration.
RCRs are calculated as ADP-stimulated State 3 respiration divided by oligomycin-
linked respiration (RCR-A) and by MAX respiration divided by oligomycin-linked
respiration (RCR-F).
In permeabilized muscle ﬁber preparations, basal respiration was measured with
no added substrates, leak was measured with malate added, complex I OXPHOS
capacity was measured using pyruvate, glutamate, and malate with a saturating
amount of ADP. Complex Iþ II OXPHOS capacity was measured using complex I
substrates with succinate added. Cytochrome C Membrane Integrity was measured
with Complex Iþ II substrates with cytochrome c added. MAX respiration was
measured using complex Iþ II substrates with FCCP titrations added. Non-mi-
tochondrial respiration was measured with MAX substrates with antimycin-A and
rotenone substrates added.
In isolated mitochondrial preparations, CII respiration was measured using succi-
nate and rotenone as substrates and using ADP, oligomycin, and FCCP injections to
measure State 3, oligomycin, and MAX, respectively.
Table 3
Relationship between monocyte bioenergetics with skeletal and cardiac muscle
bioenergetics. Pearson correlations and 95% conﬁdence intervals of monocyte re-
spiratory parameters with bioenergetics from permeabilized skeletal muscle ﬁbers
and isolated mitochondria from vastus lateralis and cardiac tissue.
Basal (95% CI) MAX (95% CI) Reserve (95% CI)
Permeabilized ﬁbers:
Basal 0.43 (0.74 to
0.03)
0.42 (0.74 to
0.03)
0.33 (0.65 to
0.17)
Complex I OXPHOS 0.74 (0.42–0.91) 0.73 (0.33–0.91) 0.60 (0.03–0.91)
Complex Iþ II
OXPHOS
0.79 (0.49–0.96) 0.75 (0.38–0.97) 0.57 (0.06–0.92)
MAX 0.09 (0.51 to
0.73)
0.01 (0.59 to
0.70)
0.20 (0.67 to
0.57)
Left vastus CII:
State 3 0.24 (0.73 to
0.55)
0.24 (0.79 to
0.63)
0.23 (0.86 to
0.67)
MAX 0.20 (0.73 to
0.55)
0.18 (0.76 to
0.56)
0.13 (0.79 to
0.62)
RCR-A 0.87 (0.58–0.96) 0.83 (0.49–0.97) 0.69 (0.22–0.98)
RCR-F 0.71 (0.30–0.91) 0.70 (0.35–0.89) 0.62 (0.10–0.89)
Cardiac CII:
State 3 0.06 (0.36 to
0.68)
0.09 (0.40 to
0.64)
0.14 (0.45 to
0.64)
MAX 0.16 (0.29 to
0.85)
0.19 (0.32 to
0.82)
0.22 (0.43 to
0.74)
RCR-A 0.49 (0.14–0.81) 0.55 (0.22–0.86) 0.58 (0.28–0.87)
RCR-F 0.52 (0.21 to
0.98)
0.50 (0.18 to
0.96)
0.41 (0.11 to
0.89)
CII¼complex 2, FCCP¼carbonyl cyanide-4-(triﬂuoromethoxy)phenylhydrazone,
MAX¼FCCP-linked respiration, OXPHOS¼oxidative phosphorylation capacity,
RCR¼respiratory control ratio. Bold type ¼ p-value r 0.05.
Respiration is measured as oxygen consumption rate (pmol/min/250,000 cells
[monocytes], pmol/min/mg dry weight [permeabilized ﬁbers], pmol/min/5 mg mi-
tochondrial protein [left vastus and cardiac tissues]).
Reserve capacity is calculated as the difference between MAX and Basal respiration.
RCRs are calculated as ADP-stimulated State 3 respiration divided by oligomycin-
linked respiration (RCR-A) and by MAX respiration divided by oligomycin-linked
respiration (RCR-F).
In permeabilized muscle ﬁber preparations, basal respiration was measured with
no added substrates, leak was measured with malate added, complex I OXPHOS
capacity was measured using pyruvate, glutamate, and malate with a saturating
amount of ADP. Complex Iþ II OXPHOS capacity was measured using complex I
substrates with succinate added. MAX respiration was measured using complex
Iþ II substrates with FCCP titrations added. Non-mitochondrial respiration was
measured with MAX substrates with antimycin-A and rotenone substrates added.
In isolated mitochondrial preparations, CII respiration was measured using succi-
nate and rotenone as substrates and using ADP, oligomycin, and FCCP injections to
measure State 3, oligomycin, and MAX respiration, respectively.
N¼11–12.
D.J. Tyrrell et al. / Redox Biology 10 (2016) 65–77 69isolated mitochondrial MAX from skeletal or cardiac muscle
(Fig. 2C and E). Similarly, a strong positive correlation was found
between monocyte MAX with the ADP-linked respiratory controlratio (RCR-A; R¼0.83, CI: 0.49–0.97). Monocyte MAX was strongly
positively correlated with RCR-A from cardiac muscle isolated
mitochondria also (R¼0.55, CI: 0.22–0.86).
3.3. Correlations between platelet bioenergetics with isolated mi-
tochondria from skeletal and cardiac muscle and permeabilized ske-
letal muscle ﬁbers
Correlations of platelet bioenergetic parameters with skeletal
and cardiac muscle bioenergetics are summarized in Table 4. Pla-
telet MAX was signiﬁcantly positively associated with complex Iþ II
OXPHOS in permeabilized skeletal muscle ﬁbers (R¼0.51, CI: 0.05–
0.81; Fig. 3A). Platelet reserve capacity was associated with complex
Iþ II OXPHOS in permeabilized muscle ﬁbers (R¼0.61, CI: 0.22–
0.85). Platelet MAX and reserve capacity were also signiﬁcantly
positively correlated with permeabilized skeletal muscle MAX un-
coupled respiration (R¼0.44, CI: 0.05–0.74; R¼0.58, CI: 0.21–0.85;
respectively). Like monocyte MAX, platelet MAX was signiﬁcantly
positively correlated with both RCR-F and RCR-A from skeletal
muscle isolated mitochondria (R¼0.64, CI: 0.23–0.89, Fig. 3D;
R¼0.53, CI: 0.16–0.83; respectively). Platelet reserve capacity was
Fig. 2. Associations among CD14þ monocyte bioenergetic parameters with skeletal and cardiac muscle bioenergetics. Regressions between monocyte maximal uncoupled
respiration and reserve capacity with respiratory control ratio and maximal uncoupled respiration from isolated mitochondria from skeletal and cardiac muscle as well as
maximal oxidative phosphorylation capacity and maximal uncoupled respiration from permeabilized skeletal muscle ﬁbers. Pearson's correlations and p-values for each
association are shown.
D.J. Tyrrell et al. / Redox Biology 10 (2016) 65–7770also signiﬁcantly positively correlated with RCR-F and RCR-A as well
as skeletal muscle isolated mitochondrial MAX (R¼0.59, CI:
0.18–0.87) and state 3 bioenergetic capacity (R¼0.57, CI: 0.17–0.80).In addition, platelet MAX was signiﬁcantly positively correlated to
RCR-F and RCR-A of cardiac isolated mitochondria (R¼0.58, CI:
0.22–0.85, Fig. 3F; R¼0.42, CI: 0.03–0.80; respectively).
Table 4
Relationship between platelet bioenergetics with skeletal and cardiac muscle bioenergetics. Pearson correlations and 95% conﬁdence intervals of platelet respiratory
parameters with bioenergetics from permeabilized skeletal muscle ﬁbers and isolated mitochondria from vastus lateralis and cardiac tissue.
Basal (95% CI) MAX (95% CI) Reserve (95% CI)
Permeabilized ﬁbers:
Basal 0.06 (0.53 to 0.42) 0.10 (0.56 to 0.57) 0.27 (0.61 to 0.74)
Complex I OXPHOS 0.19 (0.39 to 0.67) 0.34 (0.21 to 0.72) 0.45 (0.04 to 0.79)
Complex Iþ II OXPHOS 0.34 (0.25 to 0.81) 0.51 (0.05–0.81) 0.61 (0.22–0.85)
MAX 0.26 (0.29 to 0.81) 0.44 (0.05–0.74) 0.58 (0.21–0.88)
Left vastus CII:
State 3 0.05 (0.46 to 0.64) 0.32 (0.06 to 0.64) 0.57 (0.17–0.80)
MAX 0.12 (0.46 to 0.72) 0.36 (0.07 to 0.70) 0.59 (0.18–0.87)
RCR-A 0.40 (0.24 to 0.87) 0.53 (0.16–0.83) 0.56 (0.10–0.87)
RCR-F 0.49 (0.18 to 0.93) 0.64 (0.23–0.89) 0.69 (0.35–0.90)
Cardiac CII:
State 3 0.26 (0.66 to 0.29) 0.08 (0.53 to 0.47) 0.18 (0.31 to 0.68)
MAX 0.16 (0.61 to 0.41) 0.01 (0.48 to 0.54) 0.22 (0.31 to 0.70)
RCR-A 0.35 (0.04 to 0.74) 0.42 (0.03–0.80) 0.42 (0.07–0.75)
RCR-F 0.56 (0.18–0.86) 0.58 (0.22–0.85) 0.46 (0.03–0.81)
CII¼complex 2, FCCP¼carbonyl cyanide-4-(triﬂuoromethoxy) phenylhydrazone, MAX¼FCCP-linked respiration, OXPHOS¼oxidative phosphorylation capacity, RCR¼re-
spiratory control ratio. Bold type ¼ p-value r 0.05.
Respiration is measured as oxygen consumption rate (pmol/min/mg protein [platelets], pmol/min/mg dry weight [permeabilized ﬁbers], pmol/min/5 mg mitochondrial
protein [left vastus and cardiac tissues]).
Reserve capacity is calculated as the difference between MAX and Basal respiration.
RCRs are calculated as ADP-stimulated State 3 respiration divided by oligomycin-linked respiration (RCR-A) and by MAX respiration divided by oligomycin-linked respiration
(RCR-F).
In permeabilized muscle ﬁber preparations, basal respiration was measured with no added substrates, leak was measured with malate added, complex I OXPHOS capacity
was measured using pyruvate, glutamate, and malate with a saturating amount of ADP. Complex Iþ II OXPHOS capacity was measured using complex I substrates with
succinate added. MAX respiration was measured using complex Iþ II substrates with FCCP titrations added. Non-mitochondrial respiration was measured with MAX sub-
strates with antimycin-A and rotenone substrates added.
In isolated mitochondrial preparations, CII respiration was measured using succinate and rotenone as substrates and using ADP, oligomycin, and FCCP injections to measure
State 3, oligomycin, and MAX respiration, respectively.
N¼16–17.
D.J. Tyrrell et al. / Redox Biology 10 (2016) 65–77 713.4. Partial correlations between monocyte bioenergetics with iso-
lated mitochondria from skeletal and cardiac muscle and permeabi-
lized skeletal muscle
Partial correlations between monocytes with permeabilized
skeletal muscle ﬁbers, independently controlling for age, weight,
and HOMA-IR, are summarized in Table 5. When controlled for
weight, correlations between monocyte cellular respiration with
permeabilized skeletal muscle complex Iþ II OXPHOS were no
longer statistically signiﬁcant, indicating a possible interaction
between bioenergetic function with weight (Table 5). The statis-
tically signiﬁcant relationships between monocyte respiration
with isolated mitochondria from skeletal muscle were weakened
after controlling for age, weight, and HOMA-IR for RCR-F. Con-
trolling for weight reduced the strength of the associations be-
tween monocyte reserve capacity with complex I and Iþ II OX-
PHOS, and isolated skeletal muscle mitochondrial RCR-F and RCR-
A. The only relationship that persisted between monocyte bioe-
nergetics with cardiac isolated mitochondria was between
monocyte reserve capacity and RCR-A when controlling for weight
(Table 6).
3.5. Partial correlations between platelet bioenergetics with isolated
mitochondria from skeletal and cardiac muscle and permeabilized
skeletal muscle
Partial correlations between platelets with isolated mitochon-
dria from skeletal and cardiac muscle and permeabilized skeletal
muscle ﬁbers, independently controlling for age, weight, and
HOMA-IR, are summarized in Table 5. Platelet reserve capacity
signiﬁcantly positively correlated with permeabilized skeletal
muscle complex Iþ II OXPHOS and MAX uncoupled respiration
after independently controlling for age, weight, and HOMA-IR
using partial correlations (Table 5). Relationships between cardiac
isolated mitochondria were weakened except platelet reserveremained correlated with RCR-A when controlling for weight and
platelet basal, MAX, and reserve positively correlated with RCR-F
when controlling for HOMA-IR (Table 7).4. Discussion
Mitochondrial dysfunction is a primary driver of many diseases,
particularly chronic pathologies associated with aging, including
obesity [47], diabetes [24], and heart failure [25]. Mitochondrial
dysfunction may be mediated by various mechanisms such as
aberrant mitophagy [12], oxidative stress [49,50], or mitochondrial
DNA heteroplasmy [51]. The cumulative effects of defects in these
pathways ultimately affect mitochondrial oxidative phosphoryla-
tion, which can be assessed by analyzing the oxygen consumption
rate of cells or isolated mitochondria [52].
Muscle mitochondrial bioenergetics has been highlighted to play
a role in diverse diseases and disorders such as obesity, diabetes,
and sarcopenia [53–55]. While muscle respirometry has sig-
niﬁcantly advanced our mechanistic understanding of mitochon-
drial bioenergetics, such measures may present undue burden in
large scale clinical trials, or studies focused on patients with con-
traindications to biopsy, such as more frail older adults. In recent
years, the potential relationships between mitochondrial function
measured in blood cells with various disease states and disorders
has gained attention [56]. This study directly addresses whether the
bioenergetic proﬁle of circulating cells are related to key aspects of
mitochondrial function measured in skeletal and cardiac muscle.
The primary ﬁnding we report is that blood cell maximal respiration
is positively correlated with multiple measures of oxidative capacity
in permeabilized muscle ﬁber bundles. The respiratory capacities of
intact blood cells and muscle ﬁbers both incorporate the cumulative
effects of intrinsic OXPHOS capacity and mitochondrial content on
overall bioenergetic capacity. Interestingly, we also found that the
maximal respiratory capacity of monocytes and platelets are
Fig. 3. Associations among platelet bioenergetic parameters with skeletal and cardiac muscle bioenergetics. Regressions between platelet maximal uncoupled respiration
and reserve capacity with respiratory control ratio and maximal uncoupled respiration from isolated mitochondria from skeletal and cardiac muscle as well as maximal
oxidative phosphorylation capacity and maximal uncoupled respiration from permeabilized skeletal muscle ﬁbers. Pearson's correlations and p-values for each association
are shown.
D.J. Tyrrell et al. / Redox Biology 10 (2016) 65–7772associated with respiratory control, a reliable measure of mi-
tochondrial coupling, measured in isolated skeletal and cardiac
muscle mitochondria [57]. These results suggest that blood cell re-
spiration is related to differences in overall bioenergetic function,
taking into account potential differences in mitochondrial content
and networking activity, as well as intrinsic ETC function. Overall,the ﬁndings reported in this manuscript support the hypothesis that
blood cell respirometry can recapitulate key readouts of systemic
bioenergetic capacity and provide a minimally-invasive index of
muscle metabolic health. Future longitudinal studies are required in
order to determine how bioenergetic capacity changes across tis-
sues with time and with disease onset/progression.
Table 5
Partial correlations between monocyte and platelet bioenergetics with permeabilized skeletal muscle bioenergetics. Partial correlations and 95% conﬁdence intervals of monocyte and platelet respiratory parameters with
bioenergetics from permeabilized skeletal muscle ﬁbers left vastus lateralis, controlling for age, weight, and insulin status.
Partial (age) Partial (weight) Partial (HOMA-IR)
Permeabilized ﬁbers: Basal (95% CI) MAX (95% CI) Reserve (95% CI) Basal (95% CI) MAX (95% CI) Reserve (95% CI) Basal (95% CI) MAX (95% CI) Reserve (95% CI)
Monocytes:
Basal 0.55 (0.83 to
0.17)
0.49 (0.82 to
0.03)
0.36 (0.79 to
0.42)
0.47 (0.79 to
0.14)
0.46 (0.79 to
0.09)
0.38 (0.78 to
0.22)
0.51 (0.85 to
0.04)
0.50 (0.83 to 0.12) 0.43 (0.76 to 0.30)
Complex I OXPHOS 0.64 (0.13–0.89) 0.63 (0.13–0.90) 0.56 (0.11 to
0.90)
0.76 (0.26–0.92) 0.75 (0.26–0.92) 0.63 (0.03 to
0.91)
0.74 (0.16–0.95) 0.73 (0.13–0.95) 0.61 (0.15 to 0.91)
Complex Iþ II OXPHOS 0.71 (0.26–0.96) 0.67 (0.02–0.97) 0.52 (0.30 to
0.95)
0.79 (0.30 to
0.97)
0.75 (0.28 to 0.98) 0.57 (0.42 to
0.93)
0.79 (0.39–0.98) 0.75 (0.34–0.97) 0.57 (0.03 to 0.91)
MAX 0.19 (0.72 to
0.56)
0.27 (0.77 to
0.52)
0.37 (0.81 to
0.40)
0.21 (0.63 to
0.86)
0.12 (0.85 to 0.69) 0.07 (0.77 to
0.66)
0.06 (0.57 to 0.76) 0.05 (0.640.68) 0.25 (0.810.47)
Platelets:
Basal 0.25 (0.72 to
0.34)
0.04 (0.59 to
0.51)
0.21 (0.40 to
0.69)
0.07 (0.71 to
0.32)
0.07 (0.58 to 0.47) 0.25 (0.40 to
0.63)
0.11 (0.51 to
0.35)
0.06 (0.42 to 0.48) 0.25 (0.43 to 0.70)
Complex I OXPHOS 0.18 (0.40 to 0.69) 0.34 (0.22 to
0.78)
0.08 (0.14 to
0.79)
0.19 (0.39 to 0.60) 0.34 (0.20 to 0.66) 0.46 (0.09 to
0.79)
0.14 (0.48 to 0.60) 0.30 (0.27 to 0.65) 0.43 (0.15 to 0.74)
Complex Iþ II OXPHOS 0.34 (0.16 to 0.83) 0.52 (0.11 to
0.84)
0.60 (0.13–0.84) 0.34 (0.27 to
0.81)
0.52 (0.11–0.78) 0.62 (0.19–0.84) 0.31 (0.31 to 0.79) 0.50 (0.01–0.79) 0.60 (0.19–0.82)
MAX 0.17 (0.36 to 0.68) 0.40 (0.05 to
0.76)
0.56 (0.12–0.88) 0.25 (0.36 to
0.67)
0.43 (0.05 to 0.73) 0.57 (0.15–0.83) 0.25 (0.29 to 0.67) 0.46 (0.02 to 0.75) 0.59 (0.18–0.85)
FCCP¼carbonyl cyanide-4-(triﬂuoromethoxy) phenylhydrazone, HOMA-IR¼homeostatic model of insulin resistance, MAX¼FCCP-linked respiration, OXPHOS¼oxidative phosphorylation capacity. Bold type ¼ p-value r 0.05.
Respiration is measured as oxygen consumption rate (pmol/min/mg protein [platelets], pmol/min/250,000 cells [monocytes], and pmol/min/mg dry weight [permeabilized ﬁbers]).
Reserve capacity is calculated as the difference between MAX and Basal respiration.
In permeabilized muscle ﬁber preparations, basal respiration was measured with no added substrates, leak was measured with malate added, complex I OXPHOS capacity was measured using pyruvate, glutamate, and malate with
a saturating amount of ADP. Complex Iþ II OXPHOS capacity was measured using complex I substrates with succinate added. MAX respiration was measured using complex Iþ II substrates with FCCP titrations added. Non-
mitochondrial respiration was measured with MAX with antimycin-A and rotenone substrates added.
Monocytes: N¼12. Platelets: N¼17.
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spiratory analyses of both permeabilized muscle ﬁbers and iso-
lated mitochondria from freshly isolated tissues in a well pheno-
typed non-human primate model with high variability in age and
metabolic health are major strengths of the present study. Kava-
nagh et al. have studied metabolically healthy and unhealthy fe-
male vervet macaques and have published mean values for glucose
(60.5 mg/dL and 104.7 mg/dL; respectively), insulin (20.8 mIU/mL
and 26.5 mIU/mL; respectively), and HOMA-IR (3.04 and 6.76;
respectively). These values are similar to those measured from our
cohort over the same range of ages, although the variability is
greater in the metabolically diverse cohort of animals used for this
study [30]. The oxygen consumption rates published by Chacko
et al. for monocytes (83.9 pmol/min/250k cells) and platelets
(199.4 pmol/min/25million cells) are similar to what was mea-
sured in our study, and permeabilized ﬁbers from non-human
primates are similar to results from humans published by others
[41,58]. Similarly, respiratory control ratios of isolated skeletal and
cardiac muscle are similar to those described in human cardiac
and skeletal muscle by Park et al. (5.370.7, 3.270.4) and others
[59–61]. Altogether, we believe that the respiration rates we report
in this study are in line with previous reports by other groups.
It should be noted that fundamental methodological differ-
ences exist when measuring mitochondrial function in different
tissues and circulating cells. This limits the comparisons that can
logically be made a between the various readouts we report. Blood
cells were kept intact for respirometric assessments; however,
skeletal muscle ﬁbers are permeabilized with a mild detergent,
speciﬁc for cholesterol esters found predominantly in the plasma
membrane but not mitochondrial membranes [62]. Isolated mi-
tochondrial preparations utilized in this study focus on intrinsic
ETC properties, without potential input from non-mitochondrial
contributors to respiratory capacity or differences in mitochondrial
content. Taking these methodological differences into considera-
tion, the most straightforward comparison that can be made is
between the respiratory capacities of blood cells and muscle ﬁbers.
Indeed, we ﬁnd that these measures are signiﬁcantly positively
correlated, even after controlling for multiple covariates. For
comparisons between the respiratory capacity of intact blood cells
with isolated muscle mitochondria, we believe that RCR represents
an appropriate measure of intrinsic ETC function. It has been
proposed by Brand and Nicholls that RCR is a reliable measure of
function when using isolated mitochondria because it is highly
tissue- and substrate-dependent and changes with any alteration
in oxidative phosphorylation [57]. The relationships between
monocyte and platelet respiration with the RCR of the isolated
mitochondria suggests that higher overall respiration in blood
cells may also be related to the intrinsic coupling of the mi-
tochondria, regardless of mitochondrial content within the mus-
cle. Future studies using permeabilized blood cells and isolated
blood cell mitochondria may help to clarify these relationships. A
limitation of this study is that we report data only for complex II
driven respiration in the isolated mitochondrial preparations. Fu-
ture studies should compare both complex I and complex II driven
respiration in isolated mitochondria as well as permeabilized
blood cells.
It is clear that a range of diseases manifest with alterations in
mitochondrial function; whether they are of genetic mitochondrial
etiology, acute disruptions such as ischemia reperfusion, or
chronic as is the case with many diseases associated with aging. It
was recently demonstrated that basal and maximal bioenergetic
function measured in monocytes is reduced post-operatively
compared with healthy controls [63]. It was also shown that pa-
tients with diabetic nephropathy have reduced reserve capacity
and maximal respiration in peripheral blood mononuclear cells
with evidence that elevated circulating mitochondrial DNA may
Table 7
Partial correlations between platelet bioenergetics with skeletal and cardiac muscle bioenergetics. Partial correlations and 95% conﬁdence intervals of platelet respiratory
parameters with bioenergetics from isolated mitochondria from left vastus lateralis and cardiac tissue, controlling for age, weight, and insulin status.
Partial (age) Partial (weight) Partial (HOMA-IR)
Basal (95% CI) MAX (95% CI) Reserve
(95% CI)
Basal (95% CI) MAX (95% CI) Reserve
(95% CI)
Basal (95% CI) MAX (95% CI) Reserve
(95% CI)
Left vastus CII:
State 3 0.05 (0.52 to
0.67)
0.34 (0.02 to
0.69)
0.59 (0.20–
0.85)
0.03 (0.68 to
0.55)
0.30 (0.32 to
0.62)
0.57 (0.07–
0.80)
0.02 (0.54
to 0.59)
0.28 (0.13 to
0.66)
0.56 (0.10–0.84)
MAX 0.26 (0.32 to
0.75)
0.51 (0.11–0.81) 0.67 (0.29–
0.92)
0.10 (0.61 to
0.59)
0.35 (0.24 to
0.67)
0.58 (0.12–
0.84)
0.02 (0.52 to
0.62)
0.30 (0.18 to
0.74)
0.55 (0.05–0.90)
RCR-A 0.23 (0.27 to
0.83)
0.42 (0.04–
0.81)
0.53 (0.03–
0.83)
0.43 (0.19 to
0.85)
0.58 (0.18–
0.86)
0.63 (0.21–
0.89)
0.29 (0.31 to
0.84)
0.44 (0.00–
0.80)
0.51 (0.05 to
0.84)
RCR-F 0.56 (0.08–
0.93)
0.70 (0.39–
0.91)
0.71 (0.37–
0.92)
0.50 (0.09 to
0.93)
0.67 (0.29–
0.91)
0.73 (0.45–
0.91)
0.36 (0.25 to
0.91)
0.55 (0.08–
0.86)
0.64 (0.25–0.86)
Cardiac CII:
State 3 0.27 (0.68
to 0.28)
0.05 (0.53
to 0.44)
0.21 (0.25 to
0.65)
0.26 (0.60
to 0.11)
0.08 (0.46
to 0.31)
0.18 (0.21 to
0.53)
0.24 (0.70
to 0.40)
0.04 (0.58
to 0.54)
0.23 (0.30 to
0.70)
MAX 0.13 (0.61
to 042)
0.06 (0.48 to
0.55)
0.26 (0.23 to
067)
0.16 (0.53
to 0.21)
0.01 (0.41 to
0.37)
0.22 (0.21 to
0.58)
0.10 (0.60
to 0.40)
0.08 (0.48 to
0.55)
0.30 (0.24 to
0.71)
RCR-A 0.16 (0.49 to
0.60)
0.29 (0.41 to
0.71)
0.34 (0.28 to
0.77)
0.35 (0.16 to
0.71)
0.43 (0.13 to
0.84)
0.42 (0.01–
0.77)
0.29 (0.36 to
0.74)
0.37 (0.27 to
0.84)
0.37 (0.15 to
0.79)
RCR-F 0.46 (0.01 to
0.78)
0.49 (0.02 to
0.80)
0.39 (0.10 to
0.73)
0.56 (0.10 to
0.90)
0.58 (0.09 to
0.87)
0.46 (0.07 to
0.80)
0.60 (0.21–
0.84)
0.62 (0.24–
0.88)
0.48 (0.08–0.80)
CII¼complex 2, FCCP¼carbonyl cyanide-4-(triﬂuoromethoxy) phenylhydrazone, HOMA-IR¼homeostatic model of insulin resistance, MAX¼FCCP-linked respiration, OX-
PHOS¼oxidative phosphorylation capacity, RCR¼respiratory control ratio. Bold type ¼ p-value r 0.05.
Respiration is measured as oxygen consumption rate (pmol/min/mg protein [platelets] and pmol/min/5 mg mitochondrial protein [left vastus and cardiac tissues]).
Reserve capacity is calculated as the difference between MAX and Basal respiration.
RCRs are calculated as ADP-stimulated State 3 respiration divided by oligomycin-linked respiration (RCR-A) and by MAX respiration divided by oligomycin-linked respiration
(RCR-F).
In isolated mitochondrial preparations, CII respiration was measured using succinate and rotenone as substrates and using ADP, oligomycin, and FCCP injections to measure
State 3, oligomycin, and MAX respiration, respectively.
N¼16.
D.J. Tyrrell et al. / Redox Biology 10 (2016) 65–77 75precede the dysfunction in cellular metabolism [64,65]. Here we
demonstrate that blood based cellular respirometry is correlated
with bioenergetic measures generated by two common methods
for measuring skeletal muscle respirometry. These ﬁndings, sug-
gest potential applications in future clinical trials and the devel-
opment of reliable mitochondrial diagnostics. Monocyte and pla-
telet cellular respiration correlated with both skeletal and cardiac
muscle respiration. Platelet isolation is easy, quick, and can reliably
produce a high yield, making these cells a strong candidate for
future development as a clinical diagnostic tool. Future work to
compare the reliability of bioenergetic measurements among
various blood cell populations is still required, and future studies
should investigate the effects of speciﬁc circulating factors such as
circulating mtDNA, redox stress, cytokines, and other possible
mitochondrial damage associated molecular patterns on bioener-
getic function of blood cells. In addition, it remains to be de-
termined how blood cell bioenergetics are altered under various
disease states common to aging, and how they are affected by
interventions that promote healthy aging, including weight loss
and exercise.Funding
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